| Objective By grouping the patients with paroxysmal supraventricular tachycardia admitted to our hospital in a specific time interval,the clinical value of esophageal pacing in the treatment of sexual supraventricular tachycardia was compared and analyzed to provide a solid basis for improving the effectiveness and safety of the patients' clinical treatment,and the final aim was to ensure the formation of their hair.The curative effect and prognosis of sexual supraventricular tachycardia patients.Method 94 patients with paroxysmal supraventricular tachycardia admitted to our hospital from June 2016 to March 1818 were randomly divided into study group and control group,n=47 in each group.Patients in the study group with paroxysmal supraventricular tachycardia underwent esophageal pacing,and patients in the control group with paroxysmal supraventricular tachycardia underwent propafenone cardioversion.The medical and nursing operations involved in this study were all The appointment of high-grade and high-ranking clinical medical personnel is completed.The observation indexes include:(1)Therapeutic effect: The time and hospitalization time of patients with paroxysmal supraventricular tachycardia from different methods of treatment to paroxysmal supraventricular tachycardia were recorded.Among them,paroxysmal supraventricular tachycardia Termination of performance restores sinus rhythm;(2)Degree of pain: The pain and sedation of patients with paroxysmal supraventricular tachycardia during different treatments were recorded at different time points.The specific time points were selected before treatment(T0)and 12 hours after treatment(T1).24 hours after treatment(T2),the patient selected the visual analog scale method(VAS)for self-evaluation of self-evaluation method,the doctor selected Kuttner facial expression pain evaluation method for patient pain degree evaluation method.To evaluate the depth of sedation in patients with paroxysmal supraventricular tachycardia,the scores of the above scales were positively correlated with the degree of pain(ie,the higher the score,the heavier the pain/stagnation depth of the evaluator);(3)Stress response: The changes of vital signs at different time points in the treatment of two groups of paroxysmal supraventricular tachycardia were recorded.The specific time points were selected before treatment(T0)and 12 hours after treatment(T1).24 h after treatment(T2),specific life indicators include heart rate(HR),mean arterial pressure(MAP);(4)Adverse reactions: The incidence of adverse reactions during the treatment of two groups of paroxysmal supraventricular tachycardia was recorded.Common adverse reactions included chest pain,sinus arrest,hypotension,and premature contraction after termination;(5)Economic: Record the medical expenses incurred by two groups of patients with paroxysmal supraventricular tachycardia treated by different methods,in units of dollars;(6)Negative emotions: The changes of psychological tension in patients with paroxysmal supraventricular tachycardia before and after treatment were recorded.The evaluation method used 14 pressure perception scale(CPSS),and the score was positively correlated with the degree of psychological stress of the evaluator(ie,the score was more High,the more nervous the evaluator is);(7)Satisfaction: After the end of this treatment,patients with paroxysmal supraventricular tachycardia should be independently filled out(in special cases,they can be filled out by the patient's family members,such as patients' unconsciousness,death,etc.),which are jointly developed by the medical staff of the department.Self-designed treatment satisfaction questionnaire,the score is positively correlated with the degree of psychological stress of the evaluator(ie,the higher the score,the better the evaluator is satisfied with the treatment process).The two sets of related data obtained from the above study were statistically analyzed using statistical product and service solutions(SSPS.19)software.Results Both groups of patients with paroxysmal supraventricular tachycardia successfully completed the relevant treatment,the treatment completion rate was 100.00%.The treatment results are as follows:(1)Therapeutic effect: The time needed from the beginning of treatment to the end of paroxysmal supraventricular tachycardia in the study group was significantly less than that in the control group,and the data were all < 0.05(with statistical significance);(2)Analgesic and sedative effects: The scores of VAS,and Kuttner facial expression pain evaluation methods at both T0 were P>0.05.At T1,the results of VAS,and Kuttner facial expression pain evaluation methods were compared.At T0,the scores of VAS,Kuttner facial expression pain evaluation methods were further decreased compared with T1,but the T1,T2 time points of the study group were evaluated by VAS,Kuttner facial expression pain.The scores of the method were better than those of the control group with supraventricular supraventricular tachycardia.The scores of VAS,Kuttner facial expression pain evaluation methods in the group and the group were P<0.05;(3)Stress response: The HR and MAP values of T0 were both P>0.05.The HR and MAP values of T1 were significantly lower than those of T0 at T1,while the HR and MAP values of T2 were further compared with T1.Decreased,but the HR and MAP detection values in the study group at T1 and T2 were better than those in the control group.The HR and MAP values in the group and the time points were P<0.05.4Adverse reactions: Study group The incidence of adverse reactions was only 8.51%,and the incidence of adverse reactions in the control group was as high as 25.53%.The total ratio of adverse reactions in the treatment of patients with paroxysmal supraventricular tachycardia was P<0.05(Note: This time)There were no two or more adverse reactions in the same patient with paroxysmal supraventricular tachycardia;(4)Adverse reactions: the incidence of adverse reactions in the study group was only 8.51%,and the incidence of adverse reactions in the control group was as high as 25.53%.The total ratio of adverse reactions in the treatment of patients with paroxysmal supraventricular tachycardia was P<0.05.(Note: There were no two or more adverse reactions in the same patient with paroxysmal supraventricular tachycardia in this study);(5)Economics: There was no significant difference between the study group and the control group in the treatment of paroxysmal supraventricular tachycardia.The data were compared with P>0.05;(6)Negative emotions: The scores of CPSS scales in patients with paroxysmal supraventricular tachycardia before and after esophageal pacing were compared with P>0.05.After treatment,the scores of CPSS scales were significantly lower than before.The postpsychological tension was better than the control group before the improvement.The scores of the CPSS scale after treatment were compared with those before treatment,and the scores of CPSS scale before and after treatment were P<0.05;(7)Satisfaction: After the treatment of the patients with paroxysmal supraventricular tachycardia in the two groups,the scores of the evaluation of the treatment work(ie,the scores of the selfsatisfaction satisfaction questionnaire)were significantly higher in the study group than in the control group.P<0.05.Conclusion Esophageal pacing can effectively shorten the treatment time and improve the analgesic and sedative effect during the treatment of paroxysmal supraventricular tachycardia.This method also has certain advantages in terms of safety,which is conducive to the recovery of patients as soon as possible.Tension and good doctor-patient relationship are also positive.In the actual treatment process,it is recommended to choose esophageal pacing as the first choice for the treatment of paroxysmal supraventricular tachycardia,which is conducive to the protection of paroxysmal supraventricular tachycardia.The efficacy,prognosis and quality of life of patients with overspeed are worthy of reference in practical work. |
PDF Full Text Request